Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print February 6, 2008.
Biol Reprod 2008, 10.1095/biolreprod.107.066159
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
78/6/1002    most recent
biolreprod.107.066159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.
Agricola
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.
BIOLOGY OF REPRODUCTION 78, 1002–1006 (2008)
DOI: 10.1095/biolreprod.107.066159
© 2008 by the Society for the Study of Reproduction, Inc.


Pregnancy; 

Intrauterine Growth Retardation in Endothelial Nitric Oxide Synthase-Deficient Mice Is Established from Early Stages of Pregnancy1

Pilar Pallares 2 3 and Antonio Gonzalez-Bulnes 4

Unidad de Animalario,3 Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III, 28029 Madrid, Spain Departamento Reproduccion Animal,4 Instituto Nacional de Investigación y Tecnologia Agraria y Alimentaria, 28040 Madrid, Spain

ABSTRACT

The current study aimed to determine effects of deficiencies in nitric oxide synthase (NOS) 3 on embryo and fetal development by in vivo, noninvasive, real-time ultrasonographic assessment of phenotypic changes in Nos3-knockout pregnant mice and their wild-type counterparts. From Day 4.5 of pregnancy onwards, embryonic vesicle diameters, crown-rump lengths, and trunk diameters were obtained by serial scanning of seven adult pregnant female mice, strain B6.129P2-Nos3tm1Unc/J, N9 generation backcrossing with C57BL/6J mice, homozygous for the disruption of the endothelial NOS gene (group Nos3–/–), and 12 pregnant, wild-type C57BL/6J mice (group Nos3+/+). All the measurements increased in both genotypes throughout gestation. However, embryo length and width were significantly larger in Nos3+/+ than in Nos3–/– mice from Day 8.5, and both longitudinal and transverse diameters of the entire gestational sacs were larger in Nos3+/+ mice from Day 10.5. Assessment of the relative growth of embryos/fetuses and gestational annexes showed different patterns among Nos3–/– and Nos3+/+ mice. Throughout pregnancy, the distance between the external limit of the gestational sac and the embryo in Nos3+/+ mice diminished in longitudinal sections, or remained unaffected in transverse sections. In Nos3–/– mice, there were significant increases (P < 0.005) in the differences between embryo and gestational vesicle measurements in both longitudinal and transversal curves from Days 5.5 to 14.5, but from Day 14.5 of pregnancy onward, the changes were not significant. The results demonstrate that the processes of fetal growth retardation in the Nos3–/– mice are established from early pregnancy stages.

conceptus, early development, knockout mice, nitric oxide, pregnancy

INTRODUCTION

Nitric oxide (NO) is a key mediator and regulatory agent in a wide variety of physiological functions [1]. The NO is synthesized by a family of NO synthases (NOSs), with three isoforms: neuronal constitutive (nNOS or NOS1 [type I]), inducible NOS (iNOS or NOS2 [type II]), and endothelial constitutive (eNOS or NOS3 [type III]). The NOS3-derived NO was found to be the most important vasodilator and platelet aggregation inhibitor [2]. It is now well known that NOS3 takes part in most of the female reproductive processes (reviewed in [3, 4]), acting as an important mediator of uteroplacental blood flow during pregnancy.

The study of NOS actions is currently facilitated by the existence of mouse lines deficient for each isoform (for review, see [5, 6]). Inhibition of NOS3 in Nos3-knockout mice has been found to cause decreased placental perfusion and creates alterations in the remodeling of the uterine artery [7]. Effects are found to be related to fetal growth retardation and higher mortality at the end of gestation [7, 8]. Thus, there is a reduction in the litter size and weight of neonates at delivery (confirmed by [9]), with increased perinatal losses [6]. The publications examining fetal growth [7, 8] report that differences in litter size and fetal development were established only at the last days of pregnancy (Day 17 postcoitum [p.c.]). Conversely, several studies (for review, see [3, 4]) have emphasized the role of NO and NOS, and specifically NOS3, in processes of implantation and early embryonic development [1012]. All of these analyses were done by postmortem examination at specific gestational ages; thus, the screening of the same conceptuses in successive days throughout the pregnancy is impeded.

The current study was developed to assess the effects of deficiencies in NOS3 on fetal development. For a dynamic study of conceptus development in the same animals in successive days, in vivo monitoring of daily changes in embryonic and fetal structures during the entire gestation was performed in Nos3-knockout mice and their wild-type counterparts. The screening was carried out by real-time ultrasound imaging, a well-recognized, noninvasive, and reliable method for assessment of pregnancy and fetal development in most species, including mice [13, 14], from very early pregnancy stages (Day 4.5 p.c. in mice; Pallares and Gonzalez-Bulnes, unpublished results). From the data of another previously unpublished study (Pallares and Gonzalez-Bulnes), values of embryo vesicle and trunk diameters and crown-rump lengths of embryos and fetuses were considered to be the most representative during the entire pregnancy. These measurements can be easily made from early pregnancy stages (Day 4.5 p.c. for vesicle and 5.5 p.c. for embryo measurements) and throughout the entire gestation. Other suitable anatomical structure measurements are the skull diameter (occipito-snout length and biparietal and orbital diameters), umbilical cord diameter, and femur length, but only at later stages of gestation (from Day 11.5 onward) and with reliability determined by the position of the fetus.

MATERIAL AND METHODS

Animals and Husbandry

All the animals were maintained at the facilities of the Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Animal Laboratory Unit in Madrid, Spain, which meets the requirements of the European Union for scientific procedure establishment. Aspects of pregnancies and offspring described in the literature for deficient mice had previously been found in the animals used for the trial. The experiment was carried out under project license 156/07 from the CNIC Scientific Ethic Committee. Animal manipulations were performed in accordance with Spanish policy for animal protection RD1201/05, which meets the European Union Directive 86/609 about the protection of animals used in experimentation.

Ultrasonographic Morphometry of Conceptuses Development

For this study, we used a total of seven adult, pregnant, female mice, strain B6.129P2-Nos3tm1Unc/J, N9 generation backcrossing with C57BL/6J mice, homozygous for the disruption of the endothelial NOS gene (group Nos3–/–) and 12 pregnant wild-type C57BL/6J mice (group Nos3+/+); animals were obtained from The Jackson Laboratory (Bar Harbor, ME). Females were mated in homozygosis with B6.129P2-Nos3tm1Unc/J and C57BL/6J males at a ratio of 1:1. Every morning for 4 days, appearance of estrus was determined by evaluating the presence of a vaginal plug as a result of overnight mating. The male was removed during the same morning that the vaginal plug was confirmed; this was considered as Day 0.5 of pregnancy.

Observations were performed starting at Day 3.5, estimated as mean day of implantation [15], to Day 18.5. In order to avoid an excessive number of consecutive observations, which might damage the mouse or its conceptus, the mice were randomly divided into two groups for observation, and each group was scanned on alternating days. Each mouse was manually restrained in dorsal recumbence for ultrasound scanning, without anesthesia, in order to avoid any effect on fetal development or organ function [16], mainly heart rate, during the observations. In order to diminish animal distress, ultrasound imaging was performed without shaving the abdominal hair; the coupling between the transducer and the skin was improved by abundantly wetting the abdomen with carboxymethylcellulose gel.

Scanning was performed with two different ultrasound machines: an Aloka 2500 equipped with a multifrequency (7.5–10 MHz) sectorial array probe (Aloka Co., Tokyo, Japan), and a Siemens Antares connected to a multifrequency (7.5–10 MHz) linear array probe (Siemans Medical Solutions, Erlangen, Germany). For viewing the uterine horns and fetus in transverse, frontal, or sagittal planes, ultrasound scanning was performed by placing the transducer on one flank and moving it to the opposite flank. Thus, the probe was manipulated until the largest section of each structure was obtained. Measurements were completed after the entire examination was recorded and the mouse released to avoid further stress arising from keeping the animal restrained. Subsequently, the size of the different structures was measured with built-in electronic calipers on the cine-loop. In order to avoid individual effects derived from corpulence of the fetus, the measurements from a minimum of three different conceptuses (range: 3–5 in Nos3–/– and 3–7 in Nos3+/+), from each individual pregnancy, were taken in each scanning.

Data Analysis

Data obtained were grouped according to the day of gestation, and a statistical study was carried out by using standard linear and quadratic analyses. Predictive regression curves for each variable were calculated by the best adjustment of data in terms of their respective determination coefficients (r2). The effects of genotype on correlations between day of gestation and embryonic or fetal measurements were tested by analysis of variance for repeated measures (split-plot ANOVA). The parameter values were expressed as means ± SEM, and statistical significance was accepted for P < 0.05.

RESULTS

Embryonic vesicles were identified from Day 4.5 post-vaginal plug and throughout the entire pregnancy (Fig. 1). The longitudinal diameters of the embryonic vesicle increased exponentially (Fig. 2A) from the first visualization to Day 18.5, both in Nos3–/– (y = 2.2068e0.1208x; r2 = 0.674; P < 0.0005) and Nos3+/+ (y = 2.8702e0.1132x; r2 = 0.671; P < 0.0005), the diameters being significantly higher in Nos3+/+ from Day 10.5 (10.0 ± 0.3 vs. 7.7 ± 0.2; P < 0.0005). The transverse diameter of the gestational sac also increased exponentially (Fig. 2B) for both groups (Nos3–/–: y = 1.3913e0.1133x; r2 = 0.723; P < 0.0005; Nos3+/+: y = 1.4274e0.1234x; r2 = 0.652; P < 0.0005). The values of transversal diameters were higher in Nos3+/+ from Day 10.5 (5.8 ± 0.2 vs. 4.8 ± 0.1; P < 0.005).


Figure 01
View larger version (85K):
[in this window]
[in a new window]
[Download PPT slide]
 
FIG. 1. Examples of ultrasonographic imaging and measurement of the gestational structures at different stages of pregnancy in Nos3-knockout mice. A) Longitudinal and transverse diameters of the embryonic vesicle at Day 6.5 of pregnancy. B) Crown-rump length (CRL). C) Transverse diameter (DTC) in an embryo on Day 5.5.


Figure 02
View larger version (5K):
[in this window]
[in a new window]
[Download PPT slide]
 
FIG. 2. Regression curves showing the relationship of the longitudinal (A) and transverse (B) diameters of the embryonic vesicles with gestational age in Nos3-knockout mice (Nos3–/–, solid circles, solid line) and wild-type controls (Nos3+/+, open circles, dashed line).

The crown-rump length and trunk diameter of the embryos and fetuses were measured from Day 5.5 to Day 18.5 of gestation (Fig. 3). The evolution of the crown-rump length was exponential in both groups (Nos3–/–: y = 1.5149e0.1053x; r2 = 0.776; P < 0.0005; Nos3+/+: y = 1.4274e0.1234x; r2 = 0.652; P < 0.005), like the trunk diameter (Nos3–/–: y = 0.6971e0.1089x; r2 = 0.783; P < 0.0005; Nos3+/+: y = 1.2392e0.0952x; r2 = 0.588; P < 0.0005). Differences between genotypes in both parameters were found from Day 8.5 of pregnancy (for crown-rump length: 5.5 ± 0.5 vs. 4.6 ± 0.3; P < 0.005; and for trunk diameter: 2.9 ± 0.1 vs. 2.0 ± 0.1; P < 0.005).


Figure 03
View larger version (5K):
[in this window]
[in a new window]
[Download PPT slide]
 
FIG. 3. Regression curves showing the relationship of the embryo crown-rump lengths (A) and trunk diameters (B) with gestational age in Nos3-knockout mice (Nos3–/–, solid circles, solid line) and wild-type controls (Nos3+/+, open circles, dashed line).

From these results, subsequent analysis regarding the relative growth of embryos/fetuses and gestational annexes showed different patterns between Nos3–/– and Nos3+/+. In the control, Nos3+/+, the distance between the external limit of the gestational sac and the embryo diminished throughout the pregnancy (in longitudinal sections; Fig. 4A) or remained unaffected (in transverse sections; Fig. 4B). In the defective genotype, Nos3–/–, there was a trend to an increase throughout the gestation, both in longitudinal and transverse sections. In fact, both longitudinal and transverse curves are composed of an initial period of significant increases in the difference between embryo and gestational vesicle measurement (Days 5.5 to 14.5 p.c.; longitudinal: r2 = 0.752; P < 0.005; transverse: r2 = 0.772; P < 0.005), and a second period, from Day 14.5 of pregnancy onward, in which the changes were not significant.


Figure 04
View larger version (4K):
[in this window]
[in a new window]
[Download PPT slide]
 
FIG. 4. Regression curves showing the relationship of the relative measurements of embryos/fetuses and gestational annexes in longitudinal (A) and transverse (B) sections with gestational age in Nos3-knockout mice (Nos3–/–, solid circles, solid line) and wild-type controls (Nos3+/+, open circles, dashed line).

DISCUSSION

Our current data offer, for the first time, the in vivo daily screening of conceptus development in Nos3-knockout mice compared with their wild-type counterparts. These results clearly demonstrate, contrary to previous reports, that processes of fetal growth retardation described for the Nos3–/– mice are established from the early stages of pregnancy.

The comparison of growth curves between Nos3–/– and Nos3+/+mice showed differences from the very first observations. However, growth retardations in the development of the embryo and the entire gestational sac were found to reach statistical significance later, from Days 8.5 and 10.5 of pregnancy, respectively. In the mouse, at Day 8.5 of pregnancy, the development of the embryonic heart and the yolk sac blood circulation commences [17]; blood islands within the yolk sac originate both endothelial and hematopoietic cells [18]. This is a crucial period for the embryo, during which gastrulation takes place [19]. Gastrulation is the process by which the three primary germ layers (ectoderm, mesoderm, and endoderm) are established. Gastrulation also generates the extraembryonic mesoderm, which differentiates into the allantois and the mesodermal components of the chorion, amnion, and visceral yolk sac. Thus, our data confirms, in vivo, previous reports from in vitro studies regarding the importance of NO and NOS in early pregnancy. From these earlier studies, it is known that embryos with inhibition for the NOS enzyme become developmentally delayed or nonviable [10]. This fact has been related to the finding that nutrition of the embryos, before completion of the placenta, is achieved by phagocytic activity of the trophoblast [20, 21], activity which is mediated by reactive oxygen species [22]. During implantation, dilatation of uteroplacental arteries is induced by NOS3 from the extravillous trophoblast [23]. Subsequently, in the postimplantation period and during early placental development, the NO released by trophoblast NOS3 is hypothesized to be involved in tissue remodeling, immunosuppression, and vasoregulation [11], thus contributing to the maintenance of vasodilatation and to the prevention of coagulation necessary for the success of the early pregnancy [12].

Our findings, although coincidental with the studies cited above, are contradictory to previous works reporting that differences in fetal growth are only established at the end of pregnancy [7, 8]. A possible explanation for these differences may be related to the number of animals used or to the fact that these studies were only performed in late gestation (from Day 15 of pregnancy). Also, when compared postmortem, the fetal weight, and not the usual fetometric indexes (lengths and diameters of embryo/fetal head and body), were used for estimating conceptus development. From classical studies in other species, we know that the morphometric values obtained in later gestation are affected by the litter size and by individual characteristics of the fetus. These characteristics are determined both by genetic [24] and/or nutritional factors [25], with different effects on fetal weight than on fetal length or development [26, 27]. Moreover, it is essential to distinguish fetal growth from weight at term or at birth. Fetuses with the same weight may have had different growth trajectories that can only be elucidated by repeated ultrasonographic measurement throughout pregnancy [28]. These considerations may also be valid for mice. The study by Hefler et al. [8] was performed at Days 15 and 17 of pregnancy. The work of Van der Heijden et al. [7], although only giving data on embryonic weight at Day 17 and not before, reported abnormalities in the structural and cellular characteristics of the uterine artery between Days 5 and 11 of pregnancy in Nos3–/– mice, which coincides with the critical period identified in our study.

In the present study, differences between Nos3–/– and Nos3+/+ mice were not only found in the size of embryos and vesicles, but also in the growth dynamics of both structures. The comparison of the relative growth of embryos/fetuses and gestational annexes showed different patterns between Nos3–/– and Nos3+/+ mice. In the control wild-type mice, the increase of the structures throughout pregnancy is synchronous; in the mice defective for NOS3, the growth of the embryo is slower than that of its membranes and placenta for the first 14.5 days of pregnancy. In the mouse, this is the period of transition between the stages of late embryo and early fetus [29]. Possible causes for these changes in the relative size of embryos/fetuses and annexes are related to processes of intrauterine growth retardation (IUGR), preeclampsia, hydroamnios, and/or hydroallantois. However, in the current study, the accumulation of fluid may be disregarded as a cause, as it is accompanied by a significant increase of gestational sac size. Conversely, the size of the embryo vesicle decreased in Nos3–/– mice. Possible implications of IUGR and/or preeclamptic syndromes seem to be reinforced by the fact that deleterious effects were found initially in the embryo and subsequently in the annexes. Both syndromes, IUGR and pre-eclampsia, are linked. In preeclampsia, uteroplacental blood flow is compromised [30], leading to fetal growth restriction [31]. Thus, several studies indicate that a relative deficiency of placental NO synthesis is a predisposing factor for pre-eclampsia [30, 32, 33] and IUGR [34].

IUGR is a significant health concern in human medicine, being associated with mortality and morbidity during infancy and susceptibility to disease during adulthood, primarily showing coronary diseases, hypertension, and diabetes [35]. IUGR, both in humans and in animal models, has been found to develop into different types, and to differing degrees of severity. First, IUGR fetuses may be classified as "symmetrical" or "asymmetrical" (for review, see [36]). Symmetrical IUGR is characterized by a uniform reduction of the fetus and its organs from early pregnancy, and is associated with genetic and infectious factors. Asymmetrical IUGR is characterized by a reduction in size in some organs, while the remaining organs are normal. It is also associated with insufficient nutritional delivery to the fetus by maternal or placental factors during late gestation, when the requirements of the fetus are higher. Symmetrical IUGR is scarce, while asymmetrical IUGR is more abundant; thus, most studies have focused on asymmetrical IUGR. The inconveniences of research in humans led to the development of animal models, mainly rodents and sheep, for studies of maternal malnourishment and placental malfunction during late gestation [28, 36, 37].

Nevertheless, there is emerging evidence of the importance of adequate development of embryos during early pregnancy. Alterations around the time of conception, implantation, and early development may affect not only pregnancy establishment by immediate effects, but also fetal, neonatal, and adult development [3841], leading to low birthweight, premature births [42], and, later, metabolic, nervous, and cardiovascular diseases [43]. These effects are related to genetic and infectious factors [36], but also to nutritional challenges [42, 44, 45] and, mainly, maternal body composition during early pregnancy [46], which, in cows, has been described to be influenced by weight, age, and parity [47]. Coincidentally, incidence of reproductive alterations and fetal programming in NOS3 mice has also been related to parity [9]. Linking early pregnancy, NOS3, and later fetal programming, recent studies have found that placental NOS3 concentration, mainly regulated at mid-gestation, but also during early and late gestation [48], is influenced by challenges in early gestation [49], equivalent in this current study to the fifth to eighth weeks of pregnancy in humans [50].

In conclusion, our current results demonstrate that the processes of fetal growth retardation in the Nos3–/– mouse are established from early pregnancy stages.

ACKNOWLEDGMENTS

The authors appreciatively thank Dr. J. M. Redondo for cession of the mice used in this experiment and the staff of CNIC Animal Unit for skilled technical assistance. The help from A. Vidaurrazaga (Aloka España, Madrid, Spain) and I. Cisneros (RX Cisneros Electromedicina, Madrid, Spain) in providing different ultrasound machines and probes is also acknowledged.

FOOTNOTES

1Supported by Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Instituto Nacional de Investigación y Tecnologia Agraria y Alimentaria (INIA), under the collaborative project CC07-018. CNIC is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-CNIC Foundation; INIA is supported by the Spanish Ministry of Education and Science Affairs; there was no other outside funding. Back

Correspondence: 2Pilar Pallares, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Melchor Fernandez Almagro 3, 28029 Madrid, Spain. FAX: 34 91 453 12 65; e-mail: ppallares{at}cnic.es

Received: 17 October 2007.

First decision: 12 November 2007.

Accepted: 30 January 2008.

REFERENCES

  1. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120:227–237.[Abstract/Free Full Text]
  2. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239–242.[CrossRef][Medline]
  3. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des 2003; 9:359–380.[CrossRef][Medline]
  4. Thaler CD, Epel D. Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: a little dab'll do ya. Curr Pharm Des 2003; 9:399–409.[CrossRef][Medline]
  5. Mashimo H, Goyal RK. Lessons from genetically engineered animal models IV. Nitric oxide synthase gene knockout mice. Am J Physiol Gastrointest Liver Physiol 1999; 277:745–750.
  6. Gregg RA. Mouse models and the role of nitric oxide in reproduction. Curr Pharm Des 2003; 9:391–398.[CrossRef][Medline]
  7. Van der Heijden OW, Essers YP, Fazzi G, Peeters LL, De Mey JG, van Eys GJ. Uterine artery remodeling and reproductive performance are impaired in endothelial nitric oxide synthase-deficient mice. Biol Reprod 2005; 72:1161–1168.[Abstract/Free Full Text]
  8. Hefler LA, Reyes CA, O'Brien WE, Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 2001; 64:666–673.[Abstract/Free Full Text]
  9. Longo M, Jain V, Langenveld J, Vedernikov YP, Garfield RE, Hankins GD, Anderson GD, Saade GR. Enhanced growth and improved vascular function in offspring from successive pregnancies in endothelial nitric oxide synthase knockout mice. Am J Obstetr Gynecol 2004; 191:1470–1476.[CrossRef][Medline]
  10. Gouge RC, Marshburn P, Gordon BE, Nunley W, Huet-Hudson YM. Nitric oxide as a regulator of embryonic development. Biol Reprod 1998; 58:875–879.[Abstract/Free Full Text]
  11. Purcell TL, Given R, Chwalisz K, Garfield RE. Nitric oxide synthase distribution during implantation in the mouse. Mol Human Reprod 1999; 5:467–475.[Abstract/Free Full Text]
  12. Gagioti S, Scavone C, Bevilacqua E. Participation of the mouse implanting trophoblast in nitric oxide production during pregnancy. Biol Reprod 2000; 62:260–268.[Abstract/Free Full Text]
  13. Brown SD, Zurakowski D, Rodriguez DP, Dunning PS, Hurley RJ, Taylor GA. Ultrasound diagnosis of mouse pregnancy and gestational staging. Comp Med 2006; 56:262–271.[Medline]
  14. Russo M, Meomartino L, Greco A, Catone G, Cocchia N, Tortora G, Brunetti A. Pregnancy detection in mice using ultrasound. Vet Record 2007; 160:446–447.[Free Full Text]
  15. Kaufman MH. Atlas of Mouse Development. London:: Academic Press Ltd.; 1989.
  16. Mazze RI, Wilson AI, Rice SA, Baden JM. Fetal development in mice exposed to isoflurane. Teratology 1985; 32:339–345.[CrossRef][Medline]
  17. Chen LT, Hsu YC. Development of mouse embryos in vitro: preimplantation to the limb bud stage. Science 1982; 218:66–68.[Abstract/Free Full Text]
  18. Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997; 173:206–210.[CrossRef][Medline]
  19. Boucher DM, Pedersen RA. Induction and differentiation of extra-embryonic mesoderm in the mouse. Reprod Fertil Dev 1996; 8:765–777.[CrossRef][Medline]
  20. Schilesinger M, Koren Z. Mouse trophoblast cells in tissue culture. Fertil Steril 1975; 18:95–101.
  21. Pavia CS. Expression of the cell-mediated antimicrobial immunity by mouse trophoblast monolayers. J Infect Dis 1983; 147:1006–1010.[Medline]
  22. Gagioti S, Colepicilo P, Bevilacqua E. Reactive oxygen species and phagocytosis process of hemochorial trophoblast. J Braz Assoc Adv 1996; 48:37–42.
  23. Nanaev A, Chwalisz K, Frank HG, Kohnen G, Hegele-Hartung C, Kaufmann P. Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res 1995; 282:407–421.[Medline]
  24. Stephenson SK, Lambourne LJ. Prenatal growth in Romney X Southdown cross and Australian Merino sheep. Aust J Agric Res 1960; 2:1044–1063.
  25. Richardson C. Morphological parameters of intrauterine growth retardation in the newborn lamb. Vet Record 1976; 101:151–152.
  26. Wenham G. A radiographic study of early skeletal development in foetal sheep. J Agric Sci 1981; 96:39–44.[CrossRef]
  27. Wenham G. A radiographic study of the changes in skeletal growth and development of the foetus caused by poor nutrition in the pregnant ewe. Br Vet J 1981; 137:176–187.[Medline]
  28. Harding JE. The nutritional basis of the fetal origins of adult disease. Intern J Epidemiol 2001; 30:15–23.[Free Full Text]
  29. Evans HE, Sack WO. Prenatal development of domestic and laboratory mammals: growth curves, external features and selected references. Anat Histol Embryol 1973; 2:11–45.[CrossRef]
  30. Vedernikov Y, Saade GR, Garfield RE. Vascular reactivity in preeclampsia. Semin Perinatol 1999; 23:34–44.[CrossRef][Medline]
  31. Xiao R, Sorenson TK, Williams MA, Luthy DA. Influence of preeclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13:145–146.[CrossRef][Medline]
  32. Baylis C, Beinder E, Suto T, August P. Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 1998; 18:208–230.[Medline]
  33. Buhimschi IA, Saade GR, Chwalisz K, Garfield RE. The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum Reprod Update 1998; 4:25–42.[Abstract/Free Full Text]
  34. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109–142.[Medline]
  35. Barker DJP. Mothers, Babies and Health in Later Life, 2nd ed. London:: Churchill Livingstone; 1998.
  36. Anthony RV, Scheaffer AN, Wright CD, Regnault TR. Ruminant models of prenatal growth restriction. Reprod Suppl 2003; 61:183–194.[Medline]
  37. Greenwood PL, Bell AW. Consequences of intra-uterine growth retardation for postnatal growth, metabolism and pathophysiology. Reprod Suppl 2003; 61:195–206.[Medline]
  38. Edwards LJ, McMillen IC. Impact of maternal undernutrition during periconceptional period, fetal number, and fetal sex development of the hypothalamo-pituitary-adrenal axis in sheep during late gestation. Biol Reprod 2002; 66:1562–1569.[Abstract/Free Full Text]
  39. Gardner DS, Van Bon BWM, Dandrea J, Goddard PJ, May SF, Wilson V, Stephenson T, Symonds ME. Effect of periconceptional undernutrition and gender on hypothalamic-pituitary-adrenal axis function in young adult sheep. J Endocrinol 2006; 190:203–212.[Abstract/Free Full Text]
  40. Gardner DS, Buttery PJ, Daniel Z, Symonds ME. Factors affecting birth weight in sheep: maternal environment. Reproduction 2007; 106:307–312.
  41. Symonds ME, Stephenson T, Gardner DS, Budge H. Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. Reprod Fertil Dev 2007; 19:53–63.[CrossRef][Medline]
  42. Bloomfield FH, Oliver MH, Hawkins P, Campbell M, Phillips DJ, Gluckman PD, Challis JRG, Harding JE. A periconceptional nutritional origin for noninfectious preterm birth. Science 2003; 300:606.[Free Full Text]
  43. Gopalakrishnan G, Gardner DS, Dandrea J, Langley-Evans SC, Pearce S. Influence of maternal pre-pregnancy body composition and diet during early-mid pregnancy on cardiovascular function and nephron number in juvenile sheep. Br J Nutr 2005; 94:938–947.[CrossRef][Medline]
  44. Gardner DS, Pearce S, Dandrea J, Walker RM, Ramsey MM, Stephenson T, Symonds ME. Peri-implantation undernutrition programs blunted angiotensin II evoked baroreflex responses in young adult sheep. Hypertension 2004; 43:1290–1296.[Abstract/Free Full Text]
  45. Martin GB, Rodger J, Blache D. Nutritional and environmental effects on reproduction in small ruminants. Reprod Fertil Dev 2004; 16:491–501.[CrossRef][Medline]
  46. Oliver MH, Hawkins P, Harding JE. Periconceptional undernutrition alters growth trajectory and metabolic and endocrine responses to fasting in late-gestational fetal sheep. Pediatric Res 2005; 57:591–598.[CrossRef][Medline]
  47. Flis SA, Wattiaux MA. Effects of parity and supply of rumen-degraded and undegraded protein on production and nitrogen balance in Holsteins. J Dairy Sci 2005; 88:2096–2106.[Abstract/Free Full Text]
  48. Ziebell BT, Galan HL, Anthony RV, Regnault TR, Parker TA, Arroyo JA. Ontogeny of endothelial nitric oxide synthase mRNA in an ovine model of fetal and placental growth restriction. Am J Obstet Gynecol 2007; 197:420.e1–420.e5.[CrossRef][Medline]
  49. Arroyo JA, Anthony RV, Parker TA, Galan HL. Differential expression of placental and vascular endothelial nitric oxide synthase in an ovine model of fetal growth restriction. Am J Obstet Gynecol 2006; 195:771–777.[CrossRef][Medline]
  50. Otis EM, Brent R. Equivalent ages in mouse and human embryos. Anat Rec 1954; 120:33–63.[CrossRef][Medline]



This article has been cited by other articles:


Home page
ReproductionHome page
P. Pallares, R. A Garcia-Fernandez, L. M Criado, C. A Letelier, D. Esteban, J. M Fernandez-Toro, J. M Flores, and A. Gonzalez-Bulnes
Disruption of the endothelial nitric oxide synthase gene affects ovulation, fertilization and early embryo survival in a knockout mouse model
Reproduction, November 1, 2008; 136(5): 573 - 579.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
78/6/1002    most recent
biolreprod.107.066159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.
Agricola
Right arrow Articles by Pallares, P.
Right arrow Articles by Gonzalez-Bulnes, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS